StockNews.com Upgrades Merrimack Pharmaceuticals (NASDAQ:MACK) to Hold

StockNews.com upgraded shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) from a sell rating to a hold rating in a research report released on Saturday morning. Merrimack Pharmaceuticals Stock Up 0.3 % MACK opened at $12.81 on Friday. The firm has a market capitalization of $182.67 million, a P/E ratio of -106.75 and a beta […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States ,Eric Andersen ,Merrimack Pharmaceuticals ,Merrimack Pharmaceuticals Stock ,Institutional Trading Of Merrimack Pharmaceuticals ,Merrimack Pharmaceuticals Inc ,News Ratings For Merrimack Pharmaceuticals Daily ,Boothbay Fund Management ,Merrimack Pharmaceuticals Company Profile ,Get Rating ,Director Eric Andersen ,Avenue Partners ,Fund Management ,Jane Street Group ,Merrimack Pharmaceuticals Daily ,Nasdaq Mack ,Smack ,Medical ,59032810 ,Upgrade ,Stocknews Com ,